Advertisement

Liver as a Model System for Analyzing Mechanisms of Tumor Initiation and Promotion

  • Fred J. Stevens
  • Carl Peraino
Part of the Basic Life Sciences book series

Abstract

Evidence that tumorigenesis is a multistage process first emerged from experiments showing that wounding of skin previously treated with coal tar resulted in tumor formation at the wound site (1). Subsequent experiments in which physical trauma was replaced by the application of chemical irritants not intrinsically tumorigenic yielded similar results (2,3). These observations were codified by Rous, who coined the terms “initiation” and “promotion” to denote respectively (a) the production of potentially tumorigenic cells by limited carcinogen treatment and (b) the completion of the neoplastic transformation resulting from subsequent treatment with any of a wide variety of noncarcinogenic irritants and proliferative stimuli (3).

Keywords

Liver Tumor Tumor Incidence Hyperplastic Nodule Phenobarbital Treatment Skin Tumorigenesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Deelman, H.T. 1927. The part played by injury and repair in the development of cancer. Brit. Med. J. 1: 872.Google Scholar
  2. 2.
    Rous, P., and J.G. Kidd. 1941. Conditional neoplasms and subthreshold neoplastic states. J. Exp. Med. 73: 356–389.Google Scholar
  3. 3.
    Friedewald, W.F., and P. Rous. 1944. The initiating and promoting elements in tumor production. J. Exp. Med. 80: 101–125.Google Scholar
  4. 4.
    Berenblum, I. 1941. The cocarcinogenic action of croton resin. Cancer Res. 1: 41–48.Google Scholar
  5. 5.
    Berenblum, I., and P. Shubik. 1949. The persistence of latent tumor cells induced in the mouse’s skin by a single application of 9,10-dimethyl-1–2-benzanthracene. Brit. J. Cancer 3: 384–386.Google Scholar
  6. 6.
    Hecker, E. 1967. Phorbol esters from croton oil: Chemical nature and biological activities. Naturwissenschaften 54: 282–284.Google Scholar
  7. 7.
    Sivak, A. 1979. Cocarcinogenesis. Biochim. Biophys. Acta 505: 67–89.Google Scholar
  8. 8.
    Diamond, L., T.G. O’Brien, and G. Rovera. 1979. Tumor promoters: Effects on proliferation and differentiation of cells in culture. Life Sci. 23: 1979–1988.Google Scholar
  9. 9.
    Colburn, N.M. 1980. Tumor promotion and pre-neoplastic progression. In: Carcinogenesis, Volume 5: Modifiers of Chemical Carcinogenesis. T.J. Slaga, ed. Raven Press: New York. pp. 33–56.Google Scholar
  10. 10.
    Slaga, T.J., S.M. Fischer, K. Nelson, and G.L. Gleason. 1980. Studies on the mechanism of skin tumor promotion: Evidence for several stages in promotion. Proc. Natl. Acad. Sci. 77: 3659–3663.Google Scholar
  11. 11.
    Cole, L.J., and P.C. Nowell. 1965. Radiation carcinogenesis: The sequence of events. Science 150: 1782–1789.Google Scholar
  12. 12.
    Farber, E. 1973. Hyperplastic liver nodules. In: Methods in Cancer Research, Volume 7. H. Busch, ed. Academic Press: New York. pp. 345–375.Google Scholar
  13. 13.
    Farber, E. 1973. Carcinogenesis: Cellular evolution as a unifying thread: Presidential address. Cancer Res. 33: 2537–2550.Google Scholar
  14. 14.
    Teebor, G.W., and F.F. Becker. 1971. Expression and persistence of hyperplastic nodules induced by N-2-fluorenylacetamide and their relationship to hepatocarcinogenesis. Cancer Res. 31: 1–3.PubMedGoogle Scholar
  15. 15.
    Becker, F.F. 1975. Alteration of hepatocytes by subcarcinogenic exposure to N-2-fluorenylacetamide. Cancer Res. 35: 1734–1736.PubMedGoogle Scholar
  16. 16.
    Solt, D., and E. Farber. 1976. New principle for the analysis of chemical carcinogenesis. Nature 263: 701–703.CrossRefGoogle Scholar
  17. 17.
    Solt, D.B., A. Medline, and E. Farber. 1977. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am. J. Pathol. 88: 595–618.Google Scholar
  18. 18.
    Farber, E. 1980. The sequential analysis of liver cancer induction. Biochim. Biophys. Acta 605: 149–166.Google Scholar
  19. 19.
    Peraino, C., R.J.M. Fry, and E. Staffeldt. 1971. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res. 31: 1506–1512.PubMedGoogle Scholar
  20. 20.
    Ishidate, M., W. Watanabe, and S. Odashima. 1967. Effect of barbital on carcinogenic action and metabolism of 4-dimethylaminoazobenzene. Gann 58: 276–281.Google Scholar
  21. 21.
    Kunz, W., G. Schaude, and C. Thomas. 1969. The effect of phenobarbital and halogenated hydrocarbons on nitrosamine carcinogenesis. Z. Krebsforsch. 72: 291–304.PubMedCrossRefGoogle Scholar
  22. 22.
    Schulte-Hermann, R. 1978. Induction of liver growth by xenobiotic compounds and other stimuli. Crit. Rev. Toxicol. 3: 97–158.Google Scholar
  23. 23.
    Peraino, C., E.F. Staffeldt, D.A. Haugen, L.S. Lombard, F.J. Stevens, and R.J.M. Fry. 1980. Effects of varying the dietary concentration of phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. Cancer Res. 40: 3268–3273.PubMedGoogle Scholar
  24. 24.
    Tatematsu, M., K. Nakanishi, G. Murasaki, Y. Myata, M. Horise, and N. Ito. 1979. Enhancing effect of inducers of liver microsomal enzymes on induction of hyperplastic liver nodules by N-2-fluorenylacetamide in rats. 1979. J. Natl. Cancer Inst. 63: 1411–1416.Google Scholar
  25. 25.
    Takano, T., M. Tatematsu, R. Hasegawa, K. Imaida, and N. Ito. 1980. Dose-response relationship for the promoting effect of phenobarbital on the induction of liver hyperplastic nodules in rats exposed to 2-fluorenylacetamide and carbon tetrachloride. Gann 71: 580–581.PubMedGoogle Scholar
  26. 26.
    Pugh, T.D., and S. Goldfarb. 1978. Quantitative histochemical and autoradiographic studies of hepatocarcinogenesis in rats fed 2-acetylaminofluorene followed by phenobarbital. Cancer Res. 38: 4450–4457.PubMedGoogle Scholar
  27. 27.
    Watenabe, K., and G.M. Williams. 1978. Enhancement of rat hepatocellular altered foci by the liver tumor promoter phenobarbital: Evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions. J. Natl. Cancer Inst. 61: 1311–1314.Google Scholar
  28. 28.
    Weisburger, J.M., R.M. Madison, J.M. Ward, C. Vignera, and E.F. Weisburger. 1975. Modification of diethylnitrosamine liver carcinogenesis with phenobarbital but not with immunosuppression. J. Natl. Cancer Inst. 54: 1185–1188.Google Scholar
  29. 29.
    Pitot, H., L. Barsness, T. Goldsworthy, and T. Kitagawa. 1978. Biochemical characterization of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine. Nature 271: 456–458.PubMedCrossRefGoogle Scholar
  30. 30.
    Kitagawa, T., and H. Sugano. 1978. Enhancing effect of phenobarbital on the development of enzyme-altered islands and hepatocellular carcinomas initiated by 3’methyl-4-(dimethylamino)-azobenzene or diethylnitrosamine. Gann 69: 679–687.PubMedGoogle Scholar
  31. 31.
    Pitot, H.C., T. Goldsworthy, H.A. Campbell, and A. Poland. 1980. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res. 40: 3616–3620.PubMedGoogle Scholar
  32. 32.
    Shinozuka, H., and B. Lombardi. 1980. Synergistic effect of a choline-devoid diet and phenobarbital in promoting the emergence of foci with y-glutamyltranspeptidase-positive hepatocytes in the liver of carcinogen-treated rats. Cancer Res. 40: 3846–3849.PubMedGoogle Scholar
  33. 33.
    Nishizumi, M. 1976. Enhancement of diethylnitrosamine hepatocarcinogenesis in rats by exposure to polychlorinated biphenyls or phenobarbital. Cancer Lett. 2: 11–16.PubMedCrossRefGoogle Scholar
  34. 34.
    Nishizumi, M. 1979. Effect of phenobarbital, dichlorodiphenyltrichloroethane, and polychlorinated biphenyls on diethylnitrosamine-inducedGoogle Scholar
  35. hepatocarcinogenesis. Gann 70:835–837.Google Scholar
  36. 35.
    Yager, J.D., and R. Yager. 1980. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female SpragueDawley rats. Cancer Res. 40: 3680–3685.Google Scholar
  37. 36.
    Uchida, E., and I. Hirono. 1979. Effects of phenobarbital on induction of liver and lung tumors by dimethylnitrosamine in newborn mice. Gann 70: 639–644.PubMedGoogle Scholar
  38. 37.
    Kitagawa, T., T. Hirakawa, T. Ishakawa, N. Nemoto, and S. Takayama. 1980. Induction of hepatocellular carcinomas in rat liver by initial treatment with benzo[a]pyrene after partial hepatectomy and promotion by phenobarbital. Toxicol. Lett. 65: 167–171.Google Scholar
  39. 38.
    Pitot, H.C. 1979. Drugs as promoters of carcinogenesis. In: The Induction of Drug Metabolism. R.W. Estabrook, and E. Lindlaub, eds. F.K. Schattauer-Verlag: New York. pp. 471–483.Google Scholar
  40. 39.
    Peraino, C., R.J.M. Fry, and D.D. Grube. 1978. Drug-induced enhancement of hepatic tumorigenesis. In: Carcinogenesis, Volume 2. T.J. Slaga, A. Sivak, and R.K. Boutwell, eds. Raven Press: New York. pp. 421–432.Google Scholar
  41. 40.
    Kitagawa, T., H.C. Pitot, E.C. Miller, and J.A. Miller. 1979. Promotion by dietary phenobarbital of hepatocarcinogenesis by 2-methyl-N,N-dimethyl-4-aminoazobenzene in the rat. Cancer Res. 39: 112–115.PubMedGoogle Scholar
  42. 41.
    Peraino, C., R.J.M. Fry, E. Staffeldt, and J.P. Christopher. 1975. Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin and dichlorodiphenyl-trichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in rats. Cancer Res. 35: 2884–2890.PubMedGoogle Scholar
  43. 42.
    Peraino, C., R.J.M. Fry, E. Staffeldt, and J.P. Christopher. 1977. Enhancing effects of phenobarbital and butylated hydroxytoluene on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Food Cosmet. Toxicol. 5: 93–96.Google Scholar
  44. 43.
    Peraino, C., R.J.M. Fry, and E. Staffeldt. 1973. Enhancement of spontaneous hepatic tumorigenesis in C3H mice by dietary phenobarbital. J. Natl. Cancer Inst. 51: 1349–1350.Google Scholar
  45. 44.
    Thorpe, E., and A.T. Walker. 1973. The toxicology of dieldrin (HEOD). II. Comparative long-term oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, B-BC, and 2-BHC. Food Cosmet. Toxicol. 11: 433–442.Google Scholar
  46. 45.
    Ponomarkov, V., L. Tomatis, and V. Turosov. 1976. The effect of long-term administration of phenobarbitone in CF-1 mice. Cancer Lett. 1: 167–172.Google Scholar
  47. 46.
    Kitagawa, T., K. Watanabe, and H. Sugano. 1980. Induction of y-glutamyltranspeptidase activity by dietary phenobarbital in “spontaneous” hepatic tumors in C3H mice. Gann 71: 537–542.Google Scholar
  48. 47.
    Rossi, L., M. Rayera, G. Repetti, and L. Santi. 1977. Longterm administration of DDT or phenobarbital-Na in Wistar rats. Int. J. Cancer 19: 179–185.Google Scholar
  49. 48.
    Innes, J.R.M., B.M. Ulland, M.G. Valerio, L. Petrucelli, L. Fishbein, E.R. Hart, A.J. Pallota, R.R. Bates, H.L. Falk, J.J. Gart, M. Klein, I. Mitchell, and J. Peters. 1979. Bioassay of pesticides and industrial chemicals for tumorigenicity in mice: A preliminary note. J. Natl. Cancer Inst. 42: 1101–1114.Google Scholar
  50. 49.
    Tomatis, L., V. Turosov, N. Day, and R.T. Charles. 1972. The effect of long-term exposure to DDT on CF-1 mice. Int. J. Cancer 10: 489–506.Google Scholar
  51. 50.
    Turosov, V.S., N.E. Day, L. Tomatis, E. Gati, and R.T. Charles. 1973. Tumors in CF-1 mice exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 51: 983–997.Google Scholar
  52. 51.
    Tomatis, L., C. Partensky, and R. Montesano. 1973. The predictive value of mouse liver tumor induction in carcinogenicity testing: A literature survey. Int. J. Cancer 12: 1–20.Google Scholar
  53. 52.
    Terracini, B., M.C. Testa, T.R. Cabral, and N. Day. 1973. The effects of long-term feeding of DDT to BALB/c mice. Int. J. Cancer 11: 747–764.Google Scholar
  54. 53.
    Fitzhugh, 0.G., and A.A. Nelson. 1947. The chronic oral toxicity of DDT (2,2-bis(p-chlorophenyl)1,1,1-trichloroethane). J. Pharmacol. Exp. Ther. 89: 18–30.Google Scholar
  55. 54.
    Deichmann, W.B., M. Keplinge, and F. Sala. 1967. Synergism among oral carcinogens. IV. The simultaneous feeding of four tumorigens to rats. Toxicol. Appl. Pharmacol. 11: 88–103.Google Scholar
  56. 55.
    Sabine, J.R., B.J. Horton, and M.B. Wicks. 1973. Spontaneous tumors in C3H-A and C3H-AfB mice: High incidence in the United States and low incidence in Australia. J. Natl. Cancer Inst. 50: 1237–1242.Google Scholar
  57. 56.
    Peraino, C., R.J.M. Fry, and E. Staffeldt. 1977. Effects of varying the onset and duration of exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. Cancer Res. 37: 3623–3627.PubMedGoogle Scholar
  58. 57.
    Boutwell, R.K. 1964. Some biological aspects of skin carcinogenesis. Prog. Exp. Tumor Res. 4: 207–250.Google Scholar
  59. 58.
    Peraino, C., R.J.M. Fry, E. Staffeldt, and W.E. Kisieleski. 1973. Effects of varying the exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res. 33: 2701–2705.PubMedGoogle Scholar
  60. 59.
    Grube, D.D., C. Peraino, and R.J.M. Fry. 1975. The effects of dietary phenobarbital on the induction of skin tumors in hairless mice with 7,12-dimethylbenz[a]anthracene. J. Invest. Dermatol. 64: 258–262.Google Scholar
  61. 60.
    Pollard, M., and P.H. Luckert. 1979. Promotional effect of sodium barbiturate on intestinal tumors induced in rats by dimethylhydrazine. J. Natl. Cancer Inst. 63: 1089–1092.Google Scholar
  62. 61.
    Clemmesen, J., V. Fuglsang-Fredricksen, and C.N. Plum. 1974. Are anti-convulsants oncogenic? Lancet 1: 705–707.Google Scholar
  63. 62.
    Schneiderman, M.A. 1974. Phenobarbitone and liver tumors. Lancet 2: 629–630.Google Scholar
  64. 63.
    Clemmesen, J., and S. Hjalgrim-Jensen. 1978. IsGoogle Scholar
  65. phenobarbital carcinogenic? A follow-up of 8087 epileptics. Ecotoxicol. Environ. Safety 1:457–470.Google Scholar
  66. 64.
    Gold, E., L. Gordis, J. Tonascia, and M. Szklo. 1978. Increased risk of brain tumors in children exposed to barbiturates. J. Natl. Cancer Inst. 61: 1031–1034.Google Scholar
  67. 65.
    Annegers, J.F., L.T. Kurland, and W.A. Hauser. 1979. Brain tumors in children exposed to barbiturates. J. Natl. Cancer Inst. 63: 3.Google Scholar
  68. 66.
    Gold, E.B., L. Gordis, J.A. Tonascia, and M. Szklo. 1979. Brain tumors in children exposed to barbiturates. J. Natl. Cancer Inst. 63: 3–4.Google Scholar
  69. 67.
    Pitot, H.C., and A.E. Sirica. 1980. The stages of initiation and promotion in hepatocarcinogenesis. Biochim. Biophys. Acta 605: 191–215.Google Scholar
  70. 68.
    Scherer, E., and P. Emmelot. 1975. Kinetics of induction and growth of precancerous liver-cell foci, and liver tumor formation by diethylnitrosamine in the rat. Eur. J. Cancer 11: 689–696.Google Scholar
  71. 69.
    Ogawa, K.D., B. Solt, and E. Farber. 1980. Phenotypic diversity as an early property of putative preneoplastic populations in liver carcinogenesis. Cancer Res. 40: 725–733.PubMedGoogle Scholar
  72. 70.
    Pollisar, M.J., and M.B. Shimkin. 1954. A quantitative interpretation of the distribution of induced pulmonary tumors in mice. J. Natl. Cancer Inst. 15: 377–403.Google Scholar
  73. 71.
    Falconer, D.S., and J.L. Bloom. 1962. A genetic study of induced lung tumors in mice. Brit. J. Cancer 16: 665–685.Google Scholar
  74. 72.
    Drinkwater, N.R., and J.H. Klotz. 1981. Statistical methods for the analysis of tumor multiplicity data. Cancer Res. 41: 113–119.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Fred J. Stevens
    • 1
  • Carl Peraino
    • 1
  1. 1.Division of Biological and Medical ResearchArgonne National LaboratoryArgonneUSA

Personalised recommendations